1. Department of Health (2003) Abortion Statistics, England and Wales: 2002. Statistical Bulletin 2003/23. London: Department of Health.
2. Scottish Health Statistics Abortions (2002) (http://www.isdscotland.org/isd/info3.jsp?pContentID= 1919p_applic=CCC&p_service=Content.show&)
3. Birth Control Trust (1997) Abortion Provision in Britain - How Services are Provided and How they could be improved. London: Birth Control Trust.
4. Abortion Act 1967 (1967) London: HMSO.
5. Human Fertilisation and Embryology Act 1990 (1990) London: HMSO.
6. General Medical Council (1998) Maintaining Good Medical Practice. London: GMC.
7. British Medical Association (1997; revised 1999) The Law and Ethics of Abortion: BMA Views. London: BMA.
8. Royal College of Obstetricians and Gynaecologists (2004) The Care of Women Requesting Induced Abortion 2000, revised 2004. Evidence-based Guideline no 7. London: RCOG Press.
9. Sawaya GF, Grady D, Kerlikowske K & Grimes DA (1996) Antibiotics at the time of induced abortion: the case for universal prophylaxis on a meta-analysis. Obstet Gynecol 87, 884-90.
10. Blackwell AL, Thomas PD, Wereham K & Emery SJ (1993) Health gains from screening for infection of the lower genital tract in women attending for termination of pregnancy. Lancet 342,206-10.
11. Penney GC, Thomson M, Norman J et al. (1998) A randomised comparison of strategies for reducing infective complications of induced abortion. Br J Obstet Gynaecol 105, 599-604.
12. Spitz IM, Barden CW, Benton L & Robins A (1998) Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 338(18), 1241-7.
13. Bartley J, Tong S, Everington D & Baird DT (2000) Parity is major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception 62(6), 297-303.
14. Ashok PW, Templeton A, Wagaarachchi PT & Flett GM (2002) Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Br J Obstet Gynaecol 109(11), 1281-9.
15. Slade P, Heke S, Fletcher J & Stewart P (1998) A comparison of medical and surgical termination of pregnancy: choice, emotional impact and satisfaction with care. Br J Obstet Gynaecol 105(12), 1288-95.
16. Ashok PW, Kidd A, Flett GM, Fitzmaurice A, Graham W & Templeton A (2002) A randomised comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks gestation. Hum Reprod 17(1), 92-8.
17. Howie FL, Henshaw RC, Naagi SA et al. (1997) Medical abortion or vacuum aspiration? Two year follow up of a patient preference trial. Br J Obstet Gynaecol 104, 829-33.
18. Penney GC, Templeton A & Glazier A (1994) Patients' views on abortion care in Scottish Hospitals. Health Bulletin 52, 431-8.
19. Kaunitz AM, Rovira EZ, Grimes DA & Schuz KF (1985) Abortions that fail. Obstet Gynaecol 66, 533-7.
20. Kulier R, Gulmezoglua AM, Hofmeyr GJ, Cheng LN & Campana A (2004) Medical methods for first trimester abortion. Cochrane Database Syst Rev 2, CD002855.
21. World Health Organisation Task Force on Post-Ovulatory Methods for Fertility Regulation (2001) Lowering the doses of mifepristone and gemeprost for early abortion: a randomised controlled trial. Br J Obstet Gynaecol 108, 738-42.
22. Grimes DA (1997) Medical abortion in early pregnancy: a review of the evidence. Obstet Gynecol 89, 790-6.
23. el-Refaey H, Rajasekar D, Abdulla M, Calder L & Templeton A (1995) Induction of abortion with mifepristone (RU486) and oral or vaginal misoprostol. N Engl J Med 332, 983-7.
24. el-Refaey H & Templeton A (1995) Induction of abortion in the second trimester by a combination of misoprostol and mifepristone: a randomised comparison between two misoprostol regimes. Hum Reprod 10, 475-8.
25. Ashok PW, Penney GC, Flett GM & Templeton A (1998) An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 13, 2962-5.
26. Ashok PW, Templeton A, Wagaarachchi PT & Flett GMM (2002) Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Br J Obstet Gynaecol 109, 1281-9.
27. Ashok PW, Kidd A, Flett GMM, Fitzmaurice A, Graham W & Templeton A (2002) A randomised comparison of medical abortion and surgical vacuum aspiration at 10-13 weeks of gestation. Hum Reprod 17, 92-8.
28. Hamoda H, Ashok PW, Flett GM & Templeton A (2005) Uptake and efficacy of medical abortion over 9 and up to 13 weeks gestation: a review of 1076 consecutive cases. Contraception 71, 327-32.
29. Webster D, Penney GC & Templeton A (1996) A comparison of 600 and 200 mg mifepristone prior to second trimester abortion with the prostaglandin misoprostol. Br J Obstet Gynaecol 103, 706-9.
30. Ashok PW, Templeton A, Wagaarachchi PT & Flett GM (2004) Mid trimester medical termination of pregnancy: a review of 1002 consecutive cases. Contraception 69(1), 51-8.
31. Hamoda H, Ashok PW, Flett GM & Templeton A (2004) Analgesia requirements and predictors of analgesia use for women undergoing medical abortion up to 22 weeks of gestation. Br J Obstet Gynaecol 111, 996-1000.
32. Creinin MD & Edwards J (1997) Early abortion: surgical and medical options. Curr Probl Obstet Gynecol Fertil 20, 6-32.
33. Paul ME, Mitchell CM, Rogers AJ, Fox MC & Lackie EG (2002) Early surgical abortion; efficacy and safety. Am J Obstet Gynecol 187,407-11.
34. Henshaw RC & Templeton AA (1991) Pre-operative cervical preparation before 1st trimester vacuum aspiration; a randomised controlled comparison between gemeprost and mifepristone (RU486). Br J Obstet Gynaecol 98, 1025-30.
35. Fong YF, Singh Kuldip & Prasad RNV (1998) A comparative study using two dose regimens (200 ßg and 400 ßg) of vaginal misoprostol for preoperative cervical dilatation in first trimester nulliparae. Br J Obstet Gynaecol 105,
36. Autry AM, Hayes EC, Jacobson GF & Kirby RS (2002) A comparison of medical induction and dilatation in evacuation for second-trimester abortion. Am J Obstet Gynecol 187, 393-7.
37. Kalish RB, Chasen ST, Rosenzweig LB, Rashbaum WK & Chervenak FA (2002) Impact of mid-trimester dilatation and evacuation on subsequent pregnancy outcome. Am J Obstet Gynecol 187, 882-5.
38. Hamoda H, Critchley HOD, Paterson K, Guthrie K, Rodger M & Penney GC (2005) The acceptability of home medical abortion to women in UK settings. Br J Obstet Gynaecol 112, 781-5.
39. Hamoda H, Ashok PW, Flett GMM & Templeton A (2005) Home self-administration of misoprostol for medical abortion up to 56 days gestation. J Fam Plann Reprod Health Care 31,189-92.
40. American College of Obstetrics and Gynecology Committee on Gynecology Practice (2003) ACOG Committee Opinion. Induced abortion and breast cancer risk. Int J Gynaecol Obstet 83, 233-5.
41. Beral V, Bull D, Doll R, Peto R, Reeves G & Collaborative group on hormonal factors in Breast Cancer (2004) Breast cancer and abortion; collaborative reanalysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Lancet 363, 1007-16.
42. Thorpe GM Jr, Hartmann KE & Shadigian E (2002) Long-term physical and psychological health consequences of induced abortion: review of the evidence. Obstet Gynecol Surv 58, 67-79.
43. Henriet L & Kaminski M (2001) Impact of induced abortions on subsequent pregnancy outcome: the 1995 French national perinatal survey. Br J Obstet Gynaecol 108,1036-42.
Was this article helpful?
Once your pregnancy is over and done with, your baby is happily in your arms, and youre headed back home from the hospital, youll begin to realize that things have only just begun. Over the next few days, weeks, and months, youre going to increasingly notice that your entire life has changed in more ways than you could ever imagine.